Philip Morris International Inc. Declares Regular Quarterly Dividend of $1.30 Per Share

Rhea-AI Summary

Philip Morris International Inc. (NYSE: PM) declares a regular quarterly dividend of $1.30 per common share, payable on January 10, 2024, to shareholders of record as of December 21, 2023. The ex-dividend date is December 20, 2023. PMI is a leading international tobacco company working towards a smoke-free future, investing over USD 10.5 billion in developing smoke-free products. PMI acquired Swedish Match, a leader in oral nicotine delivery, and aims to expand into wellness and healthcare areas through its Vectura Fertin Pharma business.

Positive

• PMI's strong foundation and significant expertise in life sciences.
• PMI's smoke-free products accounted for approximately 36.2% of total third-quarter 2023 net revenues.
• PMI's ambition to expand into wellness and healthcare areas through its Vectura Fertin Pharma business.

Negative

• None.

STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News:

The Board of Directors of Philip Morris International Inc. (NYSE: PM) today declared a regular quarterly dividend of $1.30 per common share, payable on January 10, 2024, to shareholders of record as of December 21, 2023. The ex-dividend date is December 20, 2023. For more details on stock, dividends and other information, see www.pmi.com/dividend.

Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested more than USD 10.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In November 2022, PMI acquired Swedish Match - a leader in oral nicotine delivery - creating a global smoke-free champion led by the companies’ IQOS and ZYN brands. The U.S. Food and Drug Administration has authorized versions of PMI’s IQOS Platform 1 devices and consumables and Swedish Match’s General snus as Modified Risk Tobacco Products. As of September 30, 2023, PMI's smoke-free products were available for sale in 82 markets, and PMI estimates that approximately 19.7 million adults around the world had already switched to IQOS and stopped smoking. Smoke-free products accounted for approximately 36.2% of PMI’s total third-quarter 2023 net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and, through its Vectura Fertin Pharma business, aims to enhance life through the delivery of seamless health experiences. For more information, please visit www.pmi.com and www.pmiscience.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20231206692360/en/

Philip Morris International

Investor Relations:

New York: +1 (917) 663 2233

Lausanne: +41 (0)58 242 4666

InvestorRelations@pmi.com

Media: David Fraser

Lausanne: +41 (0)58 242 4500

David.Fraser@pmi.com

Source: Philip Morris International

FAQ

What is the dividend declared by Philip Morris International Inc.?

Philip Morris International Inc. (NYSE: PM) declared a regular quarterly dividend of $1.30 per common share, payable on January 10, 2024, to shareholders of record as of December 21, 2023. The ex-dividend date is December 20, 2023.

What is the goal of Philip Morris International Inc.?

PMI is working towards a smoke-free future and has invested over USD 10.5 billion in developing smoke-free products with the goal of completely ending the sale of cigarettes.

What acquisition did Philip Morris International Inc. make?

PMI acquired Swedish Match, a leader in oral nicotine delivery, creating a global smoke-free champion led by the companies’ IQOS and ZYN brands.

How does Philip Morris International Inc. aim to expand into wellness and healthcare areas?

PMI aims to expand into wellness and healthcare areas through its Vectura Fertin Pharma business, with the ambition to enhance life through the delivery of seamless health experiences.